Marlene Wright Barton
Presidente presso Wright Regulatory Consulting LLC
Profilo
Marlene Wright Barton is currently working as an Operating Advisor at Revival Healthcare Capital LLC.
She is also the Chief Regulatory & Compliance Officer at Syncromune, Inc. and the President of Wright Regulatory Consulting LLC and WRC LLC.
Previously, she worked as a Senior Advisor at PTV Sciences LP and as the EVP, Chief Regulatory and Compliance Officer at ImmunSYS, Inc. Ms. Barton has a graduate degree from SUNY Empire State College and an undergraduate degree from the State University of New York at Binghamton.
Posizioni attive di Marlene Wright Barton
Società | Posizione | Inizio |
---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018. The firm is headquartered in Austin, Texas. | Consulente / Consigliere | - |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Responsabile della Conformità | 01/12/2021 |
Wright Regulatory Consulting LLC | Presidente | 01/09/2020 |
WRC LLC | Presidente | 01/01/2010 |
Precedenti posizioni note di Marlene Wright Barton
Società | Posizione | Fine |
---|---|---|
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Responsabile della Conformità | 01/09/2020 |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Investitore di Private Equity | - |
Formazione di Marlene Wright Barton
SUNY Empire State College | Graduate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Finance |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018. The firm is headquartered in Austin, Texas. | Finance |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Wright Regulatory Consulting LLC | |
WRC LLC |
- Borsa valori
- Insiders
- Marlene Wright Barton